Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07513363) titled 'The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency' on April 1.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: Single (Participant).
Primary Sponsor: Tarik Emre Sener
Condition:
Overactive Bladder
Vitamin D Deficiency
Intervention:
Behavioral: Urotherapy
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 1, 2026
Target Sample Size: 52
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT07...